Cardiology News and Research

Latest Cardiology News and Research

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.

31 Aug 2009

Intermediate dosages of otamixaban reduce acute coronary complications

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.

30 Aug 2009

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Cardiac resynchronization therapy (CRT) is a proven therapy indicated for patients with moderate to severe heart failure. Additional 24-month clinical data presented today on the European cohort of 262 patients in the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic, Inc., provides a deeper understanding of how CRT improves the function of the heart, including reduction in heart size and improvements in pumping efficiency, in certain heart failure patients with mild symptoms.

30 Aug 2009

Initial results of the CURRENT-OASIS 7 clinical trial due for release

Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona. Sanofi-aventis and Bristol-Myers Squibb, co-commercialization and co-development partners for PLAVIX(clopidogrel bisulfate), were sponsors of the study.

30 Aug 2009

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Dr. Christian Torp-Pedersen is scheduled to present detailed findings from the Phase 2b clinical trial of vernakalant (oral) at the European Society of Cardiology (ESC) Congress 2009, being held in Barcelona, Spain from August 29 to September 2, 2009.

29 Aug 2009

White paper highlights the need for more number of physician hospitals

Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.

29 Aug 2009

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

28 Aug 2009

Physician payment plan stirs concern over reform efforts

Issues surrounding physician payments and addressing the primary care doctor shortage are central to health care reform efforts.

28 Aug 2009

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.

28 Aug 2009

Bus tour campaign to raise the awareness of patient assistance programs

The 'Help is Here Express' bus tour will be stopping in Virginia throughout the week of August 31 - September 3 at various cities in order to help uninsured and financially-struggling Virginians access information on programs that provide prescription medicines for free or nearly free.

28 Aug 2009

Welch Allyn to license Inovise Medical’s AUDICOR technology following a technology agreement

Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.’s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.

28 Aug 2009

St. Jude Medical opens first Advanced Learning Center in Brussels

St. Jude Medical, Inc. (NYSE:STJ) today announced the official opening of the St. Jude Medical Advanced Learning Center, in Brussels, Belgium, offering education and training in advanced, evidence-based therapies for physicians who treat heart disease.

28 Aug 2009

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

QRS duration (QRSd) is one of several measures of heart function recorded during a routine electrocardiogram (ECG). It is a composite of waves showing the length of time it takes for an electrical signal to get all the way through the pumping chambers of the heart. Prolonged QRSd is a sign of an abnormal electrical system of the heart and is often found when the heart isn't pumping efficiently.

28 Aug 2009

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.

28 Aug 2009

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.

28 Aug 2009

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Measuring circulation in the ankle using a device similar to a blood pressure cuff can help identify asymptomatic peripheral artery disease (PAD) in stroke and transient ischemic attack (TIA) survivors, a group at much higher risk of subsequent cerebrovascular events, according to a study in Stroke: Journal of the American Heart Association.

28 Aug 2009

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, have received a Phase I Small Business Technology Transfer (STTR) contract in the amount of $100,000 to support research to identify lead antimicrobial compounds to effectively treat multi-drug resistant and biofilm-embedded bacteria.

28 Aug 2009

NIH panel releases report on the pertinence of family health history information in improving health

Though most Americans are familiar with completing a questionnaire about their family health history when visiting health care providers, an independent panel was convened by the National Institutes of Health this week to critically assess exactly what we know and what we need to learn about how this process relates to improving health.

28 Aug 2009

Study reveals the detrimental effects of high concentration levels of dangerous ultrafine particles in tunnels

A toxic cocktail of ultrafine particles is lurking inside road tunnels in concentration levels so high they have the potential to harm drivers and passengers, a new study has found.

28 Aug 2009

Study shows younger adults with high cholesterol not adhering to prescribed medications

A study released today by CVS Caremark found that more than 50 percent of patients under the age of 45 who are prescribed a medication to treat high cholesterol are not optimally adherent to their therapy.

28 Aug 2009

Cardiology News and Research

Latest Cardiology News and Research

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Intermediate dosages of otamixaban reduce acute coronary complications

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Initial results of the CURRENT-OASIS 7 clinical trial due for release

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

White paper highlights the need for more number of physician hospitals

Lawmakers, though still elbowing, agree on some health care reforms

Physician payment plan stirs concern over reform efforts

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

Bus tour campaign to raise the awareness of patient assistance programs

Welch Allyn to license Inovise Medical’s AUDICOR technology following a technology agreement

St. Jude Medical opens first Advanced Learning Center in Brussels

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

NIH panel releases report on the pertinence of family health history information in improving health

Study reveals the detrimental effects of high concentration levels of dangerous ultrafine particles in tunnels

Study shows younger adults with high cholesterol not adhering to prescribed medications

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cardiology News and Research

Latest Cardiology News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in